Home All Products Tesamorelin | Ipamorelin
Tesamorelin | Ipamorelin
Tesamorelin | Ipamorelin

Tesamorelin | Ipamorelin

Ipamorelin: Ipamorelin is a selective agonist of the ghrelin (GHS-R1a) receptor, frequently used to explore pulsatile GH-release mechanisms with minimal activity at receptors governing ACTH, cortisol, prolactin, FSH, LH, or TSH in preclinical models.

Combined Pathway Modeling
In research environments, the combination of a GHS-R1a agonist (Ipamorelin) with a GHRH analog (Tesamorelin) allows investigators to examine dual-pathway GH stimulation, including:

  • GHRH-driven GH production
  • Ghrelin-mediated pulsatile GH release
  • Potential synergistic interactions between the two pathways (Preclinical Studies)

 

Clinical References

  1. Falutz J., et al. (2007). Tesamorelin and metabolic markers in adipose tissue research. N Engl J Med, 357:2359–2370.
  2. Stanley TL., et al. (2019). Tesamorelin and liver-fat pathways in metabolic disease models. Lancet HIV, 6(12): e821–e830.
  3. Yin Y., et al. (2014). GH secretagogue receptor mechanisms and GH-releasing pathways. Int J Mol Sci, 15(3): 4837–4853.
  4. Ipamorelin Mechanistic Overview. London Inc. Magazine (2025).
  5. Tesamorelin Mechanisms Review. International Molecule Review, (2024).

*All descriptions relate exclusively to mechanistic interpretations in lab settings, not human outcomes.GH Secretion Pathway Modeling

  • Pulsatility Studies: Used to investigate patterns of GH pulse frequency and amplitude in dual-pathway stimulation models (Animal Study).

Metabolic & Lipid Pathway Studies

  • Visceral-Fat Research Models: Tesamorelin has been studied for its effects on adipocyte signaling and fat-distribution pathways in specific clinical and preclinical contexts.
(Descriptions here reflect mechanistic interest only, not therapeutic claims.)
  • Lipid-Metabolism Studies: Examined for effects on triglyceride and cholesterol-related markers in controlled research environments.

Anabolic & Tissue-Repair Pathways

  • Lean-Mass Modeling: Used to explore GH/IGF-1–linked pathways associated with protein synthesis and tissue turnover (Animal Study).

Selectivity & Off-Target Signaling

  • Receptor-Specificity Research: Ipamorelin is frequently evaluated for reduced interaction with non-GH endocrine receptors (Lab Study).

Hepatic & Inflammatory Signaling

  • Liver-Pathway Models: Tesamorelin has been used to study hepatic lipid regulation and inflammatory markers in certain preclinical and clinical research contexts.

$105.00

Per Unit
In stock

Free Shipping on All Orders $1000+